Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch-Schönlein purpura nephritis
暂无分享,去创建一个
[1] C. Daniel,et al. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. , 2013, Arthritis and rheumatism.
[2] C. Qian,et al. Regulation of Toll‐like receptor signaling pathways in innate immune responses , 2013, Annals of the New York Academy of Sciences.
[3] M. Kirchner,et al. Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosus , 2013, Pediatric Rheumatology.
[4] A. Baxter,et al. Role of toll-like receptors in multiple sclerosis. , 2013, American journal of clinical and experimental immunology.
[5] Michael Maes,et al. Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway , 2013, Molecular Neurobiology.
[6] T. Eleftheriadis,et al. Toll-like receptors and their role in renal pathologies. , 2012, Inflammation & allergy drug targets.
[7] J. Thurman,et al. Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. , 2012, Molecular immunology.
[8] G. Gumuser,et al. Assessment of Toll‐like receptor‐4 gene polymorphism on pyelonephritis and renal scar , 2012, International journal of immunogenetics.
[9] A. E. Yeo,et al. The Effects of TLR Activation on T-Cell Development and Differentiation , 2012, Clinical & developmental immunology.
[10] A. Aderem,et al. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses , 2012, Nature Immunology.
[11] R. Golub,et al. JAMA patient page. Henoch-Schönlein purpura. , 2012, JAMA.
[12] K. Mills,et al. TLR-dependent T cell activation in autoimmunity , 2011, Nature Reviews Immunology.
[13] Hong Wang,et al. TLR-signaling Networks , 2011, Journal of dental research.
[14] T. Jahnukainen,et al. Clinical course of extrarenal symptoms in Henoch–Schönlein purpura: a 6-month prospective study , 2010, Archives of Disease in Childhood.
[15] M. Banach,et al. The role of Toll-like receptors in renal diseases , 2010, Nature Reviews Nephrology.
[16] R. Camilla,et al. Toll‐like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy , 2010, Clinical and experimental immunology.
[17] J. Novak,et al. Pathogenesis of Henoch-Schönlein purpura nephritis , 2009, Pediatric nephrology (Berlin, West).
[18] H. Anders,et al. Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll‐like receptor 2 at the glomerular filtration barrier , 2009, Immunology.
[19] S. Sacks,et al. Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. , 2006, Journal of the American Society of Nephrology : JASN.
[20] P Woo,et al. EULAR/PReS endorsed consensus criteria* for the classification of childhood vasculitides , 2005, Annals of the rheumatic diseases.
[21] S. Mrusek,et al. Henoch-Schönlein purpura , 2004, The Lancet.
[22] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.